QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790M
- Status
- COMPLETED
- Phase
- PHASE2
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion
- Status
- UNKNOWN
- Phase
- PHASE2
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate Safety, Pharmacokinetics and Therapeutic Activity of RO6874281 as a Combination Therapy in Participants With Unresectable Advanced and/or Metastatic Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Outpatient Performed Pterygium Surgery Study
- Status
- WITHDRAWN
- Phase
- PHASE4
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
- Status
- COMPLETED
- Phase
- PHASE2
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2